Noguchi Emiko, Morii Wataru, Kitazawa Haruna, Hirota Tomomitsu, Sonehara Kyuto, Masuko Hironori, Okada Yukinori, Hizawa Nobuyuki
Department of Medical Genetics, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
Department of Medical Genetics, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
J Allergy Clin Immunol. 2025 Apr;155(4):1321-1332. doi: 10.1016/j.jaci.2024.11.033. Epub 2024 Dec 5.
Allergic diseases are major causes of morbidity in both developed and developing countries and represent a global burden on health care systems. Allergic sensitization is defined as the production of IgE specific to common environmental allergens and is an important indicator in the assessment of allergic diseases.
We sought to clarify the genetic basis of allergic sensitization.
We performed a genome-wide association study (GWAS) of allergic sensitization in the Japanese population followed by a cross-ancestry meta-analysis with a European population including 20,492 cases and 23,342 controls for Japanese and 8,246 cases and 16,786 controls for Europeans. We also performed a polysensitization GWAS of a Japanese population including 4,923 cases and 17,009 controls.
Allergic sensitization GWAS identified 18 susceptibility loci for Japanese only and 23 loci for the cross-ancestry population, among which 4 loci were novel. Polysensitization GWAS identified 8 significant loci. Expression quantitative trait locus colocalization analysis revealed polysensitization GWAS significant variants affecting both the phenotype and the expression of the CD28, LPP, and LRCC32 genes. Cross-population genetic correlation analysis of allergic sensitization suggested that heterogeneity exists in allergic sensitization between Europeans and Japanese, indicating that more genetic heterogeneity may exist in allergic sensitization than allergic diseases.
Our investigation provides new insights into the molecular mechanism of allergic sensitization that could enhance current understanding of allergy and allergic diseases.
过敏性疾病是发达国家和发展中国家发病的主要原因,给医疗保健系统带来了全球性负担。过敏致敏被定义为针对常见环境过敏原产生的IgE,是评估过敏性疾病的一个重要指标。
我们试图阐明过敏致敏的遗传基础。
我们对日本人群的过敏致敏进行了全基因组关联研究(GWAS),随后与欧洲人群进行了跨祖先荟萃分析,其中日本人群包括20492例病例和23342例对照,欧洲人群包括8246例病例和16786例对照。我们还对包括4923例病例和17009例对照的日本人群进行了多致敏GWAS。
过敏致敏GWAS仅在日本人群中鉴定出18个易感位点,在跨祖先人群中鉴定出23个位点,其中4个位点是新发现的。多致敏GWAS鉴定出8个显著位点。表达数量性状位点共定位分析显示,多致敏GWAS的显著变异影响CD28、LPP和LRCC32基因的表型和表达。过敏致敏的跨人群遗传相关性分析表明,欧洲人和日本人在过敏致敏方面存在异质性,这表明过敏致敏中可能存在比过敏性疾病更多的遗传异质性。
我们的研究为过敏致敏的分子机制提供了新的见解,可能会增进目前对过敏和过敏性疾病的理解。